Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Hepatitis

Free Subscription Articles published in PLoS Pathog Retrieve available abstracts of 31 articles: HTML format

Single Articles

February 2023
1. CHEN S, Harris M
   NS5A domain I antagonises PKR to facilitate the assembly of infectious hepatitis C virus particles.
   PLoS Pathog. 2023;19:e1010812.
   PubMed     Abstract available
   
   
   November 2022
2. MAZOUZ S, Salinas E, Bedard N, Filali A, et al
   Differential immune transcriptomic profiles between vaccinated and resolved HCV reinfected subjects.
   PLoS Pathog. 2022;18:e1010968.
   PubMed     Abstract available
   
   
   October 2022
3. ISKEN O, Pham MT, Schwanke H, Schlotthauer F, et al
   Characterization of a multipurpose NS3 surface patch coordinating HCV replicase assembly and virion morphogenesis.
   PLoS Pathog. 2022;18:e1010895.
   PubMed     Abstract available
   
   
   August 2022
4. HERVOUET K, Ferrie M, Ankavay M, Montpellier C, et al
   An Arginine-Rich Motif in the ORF2 capsid protein regulates the hepatitis E virus lifecycle and interactions with the host cell.
   PLoS Pathog. 2022;18:e1010798.
   PubMed     Abstract available
   
   
   
5. SHIRASAKI T, Feng H, Duyvesteyn HME, Fusco WG, et al
   Nonlytic cellular release of hepatitis A virus requires dual capsid recruitment of the ESCRT-associated Bro1 domain proteins HD-PTP and ALIX.
   PLoS Pathog. 2022;18:e1010543.
   PubMed     Abstract available
   
   
   July 2022
6. CARTWRIGHT HN, Barbeau DJ, Doyle JD, Klein E, et al
   Genetic diversity of collaborative cross mice enables identification of novel rift valley fever virus encephalitis model.
   PLoS Pathog. 2022;18:e1010649.
   PubMed     Abstract available
   
   
   
7. HONG X, Menne S, Hu J
   Constrained evolution of overlapping genes in viral host adaptation: Acquisition of glycosylation motifs in hepadnaviral precore/core genes.
   PLoS Pathog. 2022;18:e1010739.
   PubMed     Abstract available
   
   
   June 2022
8. HEUSS C, Rothhaar P, Burm R, Lee JY, et al
   A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo.
   PLoS Pathog. 2022;18:e1010472.
   PubMed     Abstract available
   
   
   
9. ISKEN O, Walther T, Wong-Dilworth L, Rehders D, et al
   Identification of NS2 determinants stimulating intrinsic HCV NS2 protease activity.
   PLoS Pathog. 2022;18:e1010644.
   PubMed     Abstract available
   
   
   
10. HONG X, Kawasawa YI, Menne S, Hu J, et al
    Host cell-dependent late entry step as determinant of Hepatitis B virus infection.
    PLoS Pathog. 2022;18:e1010633.
    PubMed     Abstract available
    
    
    
11. KIM ES, Zhou J, Zhang H, Marchetti A, et al
    Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA.
    PLoS Pathog. 2022;18:e1010576.
    PubMed     Abstract available
    
    
    May 2022
12. HUM NR, Bourguet FA, Sebastian A, Lam D, et al
    MAVS mediates a protective immune response in the brain to Rift Valley fever virus.
    PLoS Pathog. 2022;18:e1010231.
    PubMed     Abstract available
    
    
    March 2022
13. DORNBRACK K, Beck J, Nassal M
    Relaxing the restricted structural dynamics in the human hepatitis B virus RNA encapsidation signal enables replication initiation in vitro.
    PLoS Pathog. 2022;18:e1010362.
    PubMed     Abstract available
    
    
    February 2022
14. ALZAHRANI N, Wu MJ, Sousa CF, Kalinina OV, et al
    SPCS1-Dependent E2-p7 processing determines HCV Assembly efficiency.
    PLoS Pathog. 2022;18:e1010310.
    PubMed     Abstract available
    
    
    January 2022
15. LIN J, Yin L, Xu XZ, Sun HC, et al
    Bay41-4109-induced aberrant polymers of hepatitis b capsid proteins are removed via STUB1-promoted p62-mediated macroautophagy.
    PLoS Pathog. 2022;18:e1010204.
    PubMed     Abstract available
    
    
    
16. OGEGA CO, Skinner NE, Flyak AI, Clark KE, et al
    B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection.
    PLoS Pathog. 2022;18:e1010179.
    PubMed     Abstract available
    
    
    
17. SABARIEGOS R, Ortega-Prieto AM, Diaz-Martinez L, Grande-Perez A, et al
    Guanosine inhibits hepatitis C virus replication and increases indel frequencies, associated with altered intracellular nucleotide pools.
    PLoS Pathog. 2022;18:e1010210.
    PubMed     Abstract available
    
    
    December 2021
18. SAADI F, Chakravarty D, Kumar S, Kamble M, et al
    CD40L protects against mouse hepatitis virus-induced neuroinflammatory demyelination.
    PLoS Pathog. 2021;17:e1010059.
    PubMed     Abstract available
    
    
    November 2021
19. LIU H, Cheng J, Viswanathan U, Chang J, et al
    Amino acid residues at core protein dimer-dimer interface modulate multiple steps of hepatitis B virus replication and HBeAg biogenesis.
    PLoS Pathog. 2021;17:e1010057.
    PubMed     Abstract available
    
    
    September 2021
20. SUN L, Li Y, Misumi I, Gonzalez-Lopez O, et al
    IRF3-mediated pathogenicity in a murine model of human hepatitis A.
    PLoS Pathog. 2021;17:e1009960.
    PubMed     Abstract available
    
    
    
21. DANESH G, Virlogeux V, Ramiere C, Charre C, et al
    Quantifying transmission dynamics of acute hepatitis C virus infections in a heterogeneous population using sequence data.
    PLoS Pathog. 2021;17:e1009916.
    PubMed     Abstract available
    
    
    
22. WANG B, Zhu Y, Yu C, Zhang C, et al
    Hepatitis C virus induces oxidation and degradation of apolipoprotein B to enhance lipid accumulation and promote viral production.
    PLoS Pathog. 2021;17:e1009889.
    PubMed     Abstract available
    
    
    August 2021
23. BURCHILL MA, Salomon MP, Golden-Mason L, Wieland A, et al
    Single-cell transcriptomic analyses of T cells in chronic HCV-infected patients dominated by DAA-induced interferon signaling changes.
    PLoS Pathog. 2021;17:e1009799.
    PubMed     Abstract available
    
    
    
24. YUE L, Li C, Xu M, Wu M, et al
    Probing the spatiotemporal patterns of HBV multiplication reveals novel features of its subcellular processes.
    PLoS Pathog. 2021;17:e1009838.
    PubMed     Abstract available
    
    
    July 2021
25. LI Y, Luo G
    Human low-density lipoprotein receptor plays an important role in hepatitis B virus infection.
    PLoS Pathog. 2021;17:e1009722.
    PubMed     Abstract available
    
    
    
26. OLESEN CH, Augestad EH, Troise F, Bukh J, et al
    In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus.
    PLoS Pathog. 2021;17:e1009720.
    PubMed     Abstract available
    
    
    
27. YU T, Yang Q, Tian F, Chang H, et al
    Glycometabolism regulates hepatitis C virus release.
    PLoS Pathog. 2021;17:e1009746.
    PubMed     Abstract available
    
    
    May 2021
28. BAUDI I, Isogawa M, Moalli F, Onishi M, et al
    Interferon signaling suppresses the unfolded protein response and induces cell death in hepatocytes accumulating hepatitis B surface antigen.
    PLoS Pathog. 2021;17:e1009228.
    PubMed     Abstract available
    
    
    April 2021
29. SCHOBEL A, Nguyen-Dinh V, Schumann GG, Herker E, et al
    Hepatitis C virus infection restricts human LINE-1 retrotransposition in hepatoma cells.
    PLoS Pathog. 2021;17:e1009496.
    PubMed     Abstract available
    
    
    March 2021
30. HARTLAGE AS, Dravid P, Walker CM, Kapoor A, et al
    Adenovirus-vectored T cell vaccine for hepacivirus shows reduced effectiveness against a CD8 T cell escape variant in rats.
    PLoS Pathog. 2021;17:e1009391.
    PubMed     Abstract available
    
    
    January 2021
31. WELLS AI, Grimes KA, Kim K, Branche E, et al
    Human FcRn expression and Type I Interferon signaling control Echovirus 11 pathogenesis in mice.
    PLoS Pathog. 2021;17:e1009252.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: